全文获取类型
收费全文 | 1528篇 |
免费 | 81篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 35篇 |
妇产科学 | 22篇 |
基础医学 | 232篇 |
口腔科学 | 26篇 |
临床医学 | 118篇 |
内科学 | 323篇 |
皮肤病学 | 33篇 |
神经病学 | 175篇 |
特种医学 | 57篇 |
外科学 | 212篇 |
综合类 | 8篇 |
一般理论 | 1篇 |
预防医学 | 84篇 |
眼科学 | 23篇 |
药学 | 163篇 |
中国医学 | 1篇 |
肿瘤学 | 101篇 |
出版年
2023年 | 8篇 |
2022年 | 13篇 |
2021年 | 26篇 |
2020年 | 22篇 |
2019年 | 31篇 |
2018年 | 34篇 |
2017年 | 17篇 |
2016年 | 22篇 |
2015年 | 25篇 |
2014年 | 37篇 |
2013年 | 41篇 |
2012年 | 96篇 |
2011年 | 88篇 |
2010年 | 39篇 |
2009年 | 51篇 |
2008年 | 75篇 |
2007年 | 62篇 |
2006年 | 68篇 |
2005年 | 61篇 |
2004年 | 70篇 |
2003年 | 46篇 |
2002年 | 69篇 |
2001年 | 54篇 |
2000年 | 40篇 |
1999年 | 43篇 |
1998年 | 15篇 |
1997年 | 20篇 |
1996年 | 17篇 |
1994年 | 11篇 |
1993年 | 14篇 |
1992年 | 31篇 |
1991年 | 24篇 |
1990年 | 24篇 |
1989年 | 33篇 |
1988年 | 32篇 |
1987年 | 37篇 |
1986年 | 16篇 |
1985年 | 20篇 |
1984年 | 20篇 |
1983年 | 16篇 |
1982年 | 8篇 |
1981年 | 9篇 |
1979年 | 12篇 |
1978年 | 9篇 |
1977年 | 13篇 |
1976年 | 7篇 |
1975年 | 9篇 |
1974年 | 8篇 |
1973年 | 14篇 |
1972年 | 21篇 |
排序方式: 共有1622条查询结果,搜索用时 0 毫秒
61.
62.
63.
64.
Lorch SA Foust R Gow A Arkovitz M Salzman AL Szabo C Vayert B Geffard M Ischiropoulos H 《Pediatric research》2000,47(6):798-805
Inhaled nitric oxide (INO) therapy is currently used clinically to selectively dilate the pulmonary vasculature and to help treat persistent pulmonary hypertension and bronchopulmonary dysplasia in the neonate. However, in the presence of oxygen or superoxide, nitric oxide forms potentially harmful reactive nitrogen species. Using an experimental mice model, we examined the effects of concurrent hyperoxia and INO on protein tyrosine nitration and cysteine S-nitrosylation in pulmonary tissue. Data showed enhanced 3-nitrotyrosine staining within the airway epithelium and alveolar interstitium of mice lungs treated with hyperoxia, which did not increase significantly with INO administration. Within the alveolar interstitium, 3-nitrotyrosine staining was localized to macrophages. S-Nitrosocysteine staining in airway epithelium was significantly enhanced with INO administration regardless of oxygen content. These data suggest that the formation of protein S-nitrosocysteine is the major protein modification during administration of INO. 相似文献
65.
66.
Szabo J 《Managed care (Langhorne, Pa.)》1997,6(8):114, 117-114, 118
67.
68.
Szabo G 《Alcohol health and research world》1997,21(1):30-41
Alcoholics frequently suffer from infectious diseases and have increased rates of some cancers, indicating that alcohol impairs the immune system, which protects the body against this type of damage. Alcohol interferes with the functions of many of the cells and molecules that are part of the immune system. For example, alcohol inhibits the functions of the cells that ingest and destroy invading microorganisms (i.e., neutrophils, monocytes, and macrophages). Both acute and chronic alcohol exposure also alter the production of signaling molecules that help coordinate the immune response (i.e., cytokines). Finally, alcohol adversely affects the functions of the cells that mediate the immune response against specific microorganisms and long-term immunity (i.e., T cells and B cells). As a result, alcoholics have an increased susceptibility to diseases caused by bacterial infections, such as tuberculosis and pneumonia. Alcoholics also may be more susceptible to infections from the virus that causes AIDS. In addition, alcohol intoxication can exacerbate the immune suppression that occurs after traumatic injuries. 相似文献
69.
Bela Szabo Rolf Urban Klaus Starke 《Naunyn-Schmiedeberg's archives of pharmacology》1993,348(6):593-600
Summary Cardiovascular and sympathetic nervous system effects of the mixed 2-adrenoceptor and imidazoline receptor agonist rilmenidine were studied in conscious rabbits chronically instrumented for the recording of the firing rate of renal sympathetic fibers. Separate experiments were carried out on pithed rabbits with electrically stimulated (2 Hz) sympathetic outflow. Drugs were administered intravenously in a cumulative manner.In conscious rabbits, rilmenidine 0.1, 0.3 and 1.0 mg kg–1 dose-dependently lowered blood pressure, renal sympathetic nerve activity, heart rate and the plasma concentration of noradrenaline and adrenaline. The effect on blood pressure and plasma catecholamines was maximal after 0.3 mg kg–1 whereas heart rate and renal sympathetic nerve activity decreased further after rilmenidine 1.0 mg kg–1. Yohimbine 0.1 and 0.5 mg kg–1, when injected subsequently, attenuated and at the higher dose abolished all effects of rilmenidine. The effects of rilmenidine were also antagonized by the 2-adrenoceptor antagonist 2-(2,3-dihydro-2-methoxy-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole HCl (RX821002; 0.1 and 0.5 mg kg–1). Yohimbine 0.1 and 0.5 mg kg–1 did not attenuate or attenuated only slightly the decrease of heart rate and renal sympathetic nerve activity produced by infusion of vasopressin. In pithed rabbits with electrically-stimulated sympathetic outflow, yohimbine 0.1 submaximally and yohimbine 0.5 mg kg–1 maximally increased the plasma noradrenaline concentration.The experiments show by direct measurement of sympathetic nerve firing and plasma catecholamines that rilmenidine causes sympathoinhibition in conscious rabbits, presumably through central sites of action. The antagonism by yohimbine, at doses which are selective for 2-adrenoceptors (vs. imidazoline receptors), demonstrates the involvement of 2-adrenoceptors in the sympatho-inhibition.Correspondence to: B. Szabo at the above address 相似文献
70.
The mechanism behind the apparent lack of effective antiviral immune response in patients with chronic hepatitis C virus (HCV) infection is poorly understood. Although multiple levels of abnormalities have been identified in innate and adaptive immunity, it remains unclear if any of the subpopulations of T cells with regulatory capacity (Tregs) contribute to the induction and maintenance of HCV persistence. In this review, we summarize the current knowledge about Tregs as they relate to HCV infection. 相似文献